Warning Letter Roundup: FDA Raps Three Firms for GMP, Other Lapses

The FDA issued warning letters to three drug manufacturing facilities for failures in their current good manufacturing practices, including lax environmental monitoring and inadequate process validations.
Source: Drug GMP Report